ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 198

$478K Total Retail Price of All Prescriptions

Rank: 67 out of 198

537 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,049 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 441 409 1 1
HYDROCODONE-ACETAMINOPHEN 439 399 S3 2 8
WARFARIN SODIUM 432 431 3 7
SIMVASTATIN 393 391 4 2
FUROSEMIDE 377 367 5 5
AMLODIPINE BESYLATE 361 345 6 4
METOPROLOL TARTRATE 355 350 7 10
OMEPRAZOLE 290 264 8 3
SERTRALINE HCL 287 265 9 25
POTASSIUM CHLORIDE 281 267 10 9
LISINOPRIL 233 228 11 6
METOPROLOL SUCCINATE 214 205 12 11
ALENDRONATE SODIUM 202 202 13 21
METFORMIN HCL 182 166 14 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 134 15 38
ATORVASTATIN CALCIUM 150 128 16 12
HYDROCHLOROTHIAZIDE 144 144 17 16
LOSARTAN-HYDROCHLOROTHIAZIDE 130 127 18 49
TRAMADOL HCL 130 123 18 15
LANTUS 117 102 20 46
TRIAMTERENE-HCTZ 116 91 21 32
DONEPEZIL HCL 112 112 22 28
NAMENDA 110 110 23 33
ALLOPURINOL 107 84 24 23
GABAPENTIN 101 101 25 14
ZOLPIDEM TARTRATE 101 93 25 22
PANTOPRAZOLE SODIUM 94 90 27 31
ADVAIR DISKUS 91 90 28 47
FAMOTIDINE 84 84 29 57
EVISTA 83 83 30 104
GLIPIZIDE ER 76 71 31 83
TAMSULOSIN HCL 65 65 32 27
PREDNISONE 64 56 33 29
ROPINIROLE HCL 61 50 34 74
CARVEDILOL 61 60 34 24
ATENOLOL 59 48 36 17
CLONIDINE HCL 58 54 37 52
LOSARTAN POTASSIUM 56 53 38 18
VENLAFAXINE HCL ER 56 41 38 84
FLUOXETINE HCL 52 52 40 78
FLUTICASONE PROPIONATE 51 46 41 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.